HEALTHCARE
Global Drug Addiction Treatment Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Drug Addiction Treatment Market, By Type (Opioid Addiction, Benzodiazepine Addiction, Barbiturate Addiction, and Others), Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, and Others), Treatment (Detoxification, Counselling and Behavioural Therapies, Rehabilitation Programs, Self-help Groups, Medications, and Others), Route of Administration (Oral, Parenteral, and Others), Treatment Centers (Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global drug addiction treatment market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
The drug addiction treatment Market is the industry that offers a variety of products and services to help those who are battling with substance misuse and addiction. This market includes a variety of interventions, such as medications, counselling and therapy services, rehabilitation facilities, support groups, and other forms of treatment.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Growing awareness and destigmatization
- Expanding insurance coverage
RESTRAINTS
- Stigma and discrimination
- Workforce shortages
OPPORTUNITIES
- Technological advancements
- Government initiatives and funding
CHALLENGES
- Treatment gaps and unmet needs
- Complexity of co-occurring disorders
SEGMENTATION
MARKET SEGMENTATION
- Type
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
- Drug Type
- Bupropion
- Varenicline
- Acamprosate
- Disulfiram
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Replacement Products
- Others
- Treatment
- Detoxification
- Counselling and Behavioural Therapies
- Rehabilitation Programs
- Self-help Groups
- Medications
- Others
- Route of Administration
- Oral
- Parenteral
- Others
- Treatment Centers
- Residential Treatment Centers
- Outpatient Treatment Centers
- Inpatient Treatment Centers
- Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Takeda Pharmaceutical Company Limited
- F. Hoffmann-La Roche Ltd
- Abbott
- Medtronic
- BD
- Johnson & Johnson Services, Inc.
- GSK Plc.
- Bayer AG
- Zimmer Biomet
- Stryker Corporation
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Drug Addiction Treatment Market, by Type
- 3.2 Global Drug Addiction Treatment Market, by Drug Type
- 3.3 Global Drug Addiction Treatment Market, by Treatment
- 3.4 Global Drug Addiction Treatment Market, by Route of Administration
- 3.5 Global Drug Addiction Treatment Market, by Treatment Centers
- 3.6 Global Drug Addiction Treatment Market, by Distribution Channel
- 3.7 Global Drug Addiction Treatment Market, by Geography
- 3.8 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Trend 1
- 5.1.2 Trend 2
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing awareness and destigmatization
- 5.2.2 Expanding insurance coverage
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Stigma and discrimination
- 5.3.2 Workforce shortages
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Technological advancements
- 5.4.2 Government initiatives and funding
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Treatment gaps and unmet needs
- 5.5.2 Complexity of co-occurring disorders
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Drug Addiction Treatment Market, by Type (2019-2032)
- SECTION 7 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY DRUG TYPE
- 7.1 Drug Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Drug Addiction Treatment Market, by Drug Type (2019-2032)
- SECTION 8 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY TREATMENT
- 8.1 Treatment Summary
- 8.2 Market Attractive Index
- 8.3 Global Drug Addiction Treatment Market, by Treatment (2019-2032)
- SECTION 9 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
- 9.1 Route of Administration Summary
- 9.2 Market Attractive Index
- 9.3 Global Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- SECTION 10 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY TREATMENT CENTERS
- 10.1 Treatment Centers Summary
- 10.2 Market Attractive Index
- 10.3 Global Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- SECTION 11 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- 11.1 Distribution Channel Summary
- 11.2 Market Attractive Index
- 11.3 Global Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- SECTION 12 - GLOBAL DRUG ADDICTION TREATMENT MARKET, BY GEOGRAPHY
- 12.1 Regional Summary
- 12.2 Market Attractive Index
- 12.3 Global Drug Addiction Treatment Market, by Geography (2019-2032)
- SECTION 13 - NORTH AMERICA DRUG ADDICTION TREATMENT MARKET
- 13.1 North America Summary
- 13.2 Market Attractive Index
- 13.3 North America Drug Addiction Treatment Market, by Type (2019-2032)
- 13.4 North America Drug Addiction Treatment Market, by Drug Type (2019-2032)
- 13.5 North America Drug Addiction Treatment Market, by Treatment (2019-2032)
- 13.6 North America Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- 13.7 North America Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- 13.8 North America Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- 13.9 North America Drug Addiction Treatment Market, by Country (2019-2032)
- 13.9.1 U.S.
- 13.9.2 Canada
- 13.9.3 Mexico
- 13.9.4 Rest of North America
- SECTION 14 - EUROPE DRUG ADDICTION TREATMENT MARKET
- 14.1 Europe Summary
- 14.2 Market Attractive Index
- 14.3 Europe Drug Addiction Treatment Market, by Type (2019-2032)
- 14.4 Europe Drug Addiction Treatment Market, by Drug Type (2019-2032)
- 14.5 Europe Drug Addiction Treatment Market, by Treatment (2019-2032)
- 14.6 Europe Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- 14.7 Europe Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- 14.8 Europe Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- 14.9 Europe Drug Addiction Treatment Market, by Country (2019-2032)
- 14.9.1 Germany
- 14.9.2 U.K.
- 14.9.3 France
- 14.9.4 Italy
- 14.9.5 Spain
- 14.9.6 Russia
- 14.9.7 The Netherlands
- 14.9.8 Belgium
- 14.9.9 Turkey
- 14.9.10 Rest of Europe
- SECTION 15 - ASIA-PACIFIC DRUG ADDICTION TREATMENT MARKET
- 15.1 Asia-Pacific Summary
- 15.2 Market Attractive Index
- 15.3 Asia-Pacific Drug Addiction Treatment Market, by Type (2019-2032)
- 15.4 Asia-Pacific Drug Addiction Treatment Market, by Drug Type (2019-2032)
- 15.5 Asia-Pacific Drug Addiction Treatment Market, by Treatment (2019-2032)
- 15.6 Asia-Pacific Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- 15.7 Asia-Pacific Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- 15.8 Asia-Pacific Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- 15.9 Asia-Pacific Drug Addiction Treatment Market, by Country (2019-2032)
- 15.9.1 China
- 15.9.2 India
- 15.9.3 Japan
- 15.9.4 South Korea
- 15.9.5 Singapore
- 15.9.6 Malaysia
- 15.9.7 Australia
- 15.9.8 Thailand
- 15.9.9 Philippines
- 15.9.10 Rest of Asia-Pacific
- SECTION 16 - SOUTH AMERICA DRUG ADDICTION TREATMENT MARKET
- 16.1 South America Summary
- 16.2 Market Attractive Index
- 16.3 South America Drug Addiction Treatment Market, by Type (2019-2032)
- 16.4 South America Drug Addiction Treatment Market, by Drug Type (2019-2032)
- 16.5 South America Drug Addiction Treatment Market, by Treatment (2019-2032)
- 16.6 South America Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- 16.7 South America Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- 16.8 South America Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- 16.9 South America Drug Addiction Treatment Market, by Country (2019-2032)
- 16.9.1 Brazil
- 16.9.2 Argentina
- 16.9.3 Chile
- 16.9.4 Colombia
- 16.9.5 Rest of South America
- SECTION 17 - MIDDLE EAST AND AFRICA DRUG ADDICTION TREATMENT MARKET
- 17.1 Middle East and Africa Summary
- 17.2 Market Attractive Index
- 17.3 Middle East and Africa Drug Addiction Treatment Market, by Type (2019-2032)
- 17.4 Middle East and Africa Drug Addiction Treatment Market, by Drug Type (2019-2032)
- 17.5 Middle East and Africa Drug Addiction Treatment Market, by Treatment (2019-2032)
- 17.6 Middle East and Africa Drug Addiction Treatment Market, by Route of Administration (2019-2032)
- 17.7 Middle East and Africa Drug Addiction Treatment Market, by Treatment Centers (2019-2032)
- 17.8 Middle East and Africa Drug Addiction Treatment Market, by Distribution Channel (2019-2032)
- 17.9 Middle East and Africa Drug Addiction Treatment Market, by Country (2019-2032)
- 17.9.1 Kingdom of Saudi Arabia
- 17.9.2 South Africa
- 17.9.3 U.A.E.
- 17.9.4 Egypt
- 17.9.5 Rest of Middle East and Africa
- SECTION 18 - COMPANY SHARE ANALYSIS
- 18.1 Global Drug Addiction Treatment Market, Company Share Analysis
- 18.2 North America Drug Addiction Treatment Market, Company Share Analysis
- 18.3 Europe Drug Addiction Treatment Market, Company Share Analysis
- 18.4 Asia-Pacific Drug Addiction Treatment Market, Company Share Analysis
- SECTION 19 - COMPANY PROFILES
- 19.1 Takeda Pharmaceutical Company Limited
- 19.1.1 Company Snapshot
- 19.1.2 Financial Overview
- 19.1.3 Product Portfolio
- 19.1.4 Recent Developments
- 19.2 F. Hoffmann-La Roche Ltd
- 19.2.1 Company Snapshot
- 19.2.2 Financial Overview
- 19.2.3 Product Portfolio
- 19.2.4 Recent Developments
- 19.3 Abbott
- 19.3.1 Company Snapshot
- 19.3.2 Financial Overview
- 19.3.3 Product Portfolio
- 19.3.4 Recent Developments
- 19.4 Medtronic
- 19.4.1 Company Snapshot
- 19.4.2 Financial Overview
- 19.4.3 Product Portfolio
- 19.4.4 Recent Developments
- 19.5 BD
- 19.5.1 Company Snapshot
- 19.5.2 Financial Overview
- 19.5.3 Product Portfolio
- 19.5.4 Recent Developments
- 19.6 Johnson & Johnson Services, Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Financial Overview
- 19.6.3 Product Portfolio
- 19.6.4 Recent Developments
- 19.7 GSK Plc.
- 19.7.1 Company Snapshot
- 19.7.2 Financial Overview
- 19.7.3 Product Portfolio
- 19.7.4 Recent Developments
- 19.8 Bayer AG
- 19.8.1 Company Snapshot
- 19.8.2 Financial Overview
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- 19.9 Zimmer Biomet
- 19.9.1 Company Snapshot
- 19.9.2 Financial Overview
- 19.9.3 Product Portfolio
- 19.9.4 Recent Developments
- 19.10 Stryker Corporation
- 19.10.1 Company Snapshot
- 19.10.2 Financial Overview
- 19.10.3 Product Portfolio
- 19.10.4 Recent Developments
- SECTION 20 - RELATED REPORTS
- SECTION 21 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.